Market Access/ News/ News NICE says yes to Braftovi combination for colorectal cancer Phil Taylor Braftovi, colorectal cancer, NHS, NICE, Pierre Fabre 0 Comment Two months after rejecting Pierre Fabre’s Braftovi for a rare form of metastatic colorectal cancer (mCRC), NICE has Share X NICE says yes to Braftovi combination for colorectal cancer https://pharmaphorum.com/news/nice-says-yes-to-braftovi-combination-for-colorectal-cancer/
Braftovi, colorectal cancer, NHS, NICE, Pierre Fabre
0 Comment
